§ 28-4552. Definitions.

Current through October 23, 2012

For the purposes of this chapter, the term:

(1) "Affected party" means any person directly or indirectly affected by excessive prices of patented prescription drugs, including any organization representing such persons or any person or organization representing the public interest.

(2) "High income country" means the United Kingdom, Germany, Canada, or Australia.

                
                    var val = document.getElementById('citecontent').innerHTML;
                    art.dialog.defaults.title = window.location.href;
                    art.dialog.data('cite', val);
                    art.dialog.data('homeDemoPath', '/Scripts/plus/artDialog/');
                    art.dialog.open('/Scripts/plus/artDialog/citeiframe.html');

(Dec. 10, 2005, D.C. Law 16-37, § 2, 52 DCR 9061.)

HISTORICAL AND STATUTORY NOTES

GENERAL NOTES

This chapter has been held unconstitutional in the case of Pharmaceutical Research and Mfrs. of America v. District of Columbia, 2005, 406 F.Supp.2d 56, 78 U.S.P.Q.2d 1822, affirmed 496 F.3d 1362, 83 U.S.P.Q.2d 1639, rehearing and rehearing en banc denied 505 F.3d 1343, 85 U.S.P.Q.2d 1144.

Legislative History of Laws

For Law 16-37, see notes following § 28-4551.